My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 105

    1.

    What is the cost of blindness?

    Meads C, Hyde C.

    Br J Ophthalmol. 2003 Oct;87(10):1201-4. Review. No abstract available. PMID: 14507746 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Quality of life and health economic assessments of age-related macular degeneration.

    Covert D, Berdeaux G, Mitchell J, Bradley C, Barnes R.

    Surv Ophthalmol. 2007 Jan;52 Suppl 1:S20-5. Review.PMID: 17240252 [PubMed - indexed for MEDLINE]Related articles

    3.

    New treatments for age-related macular degeneration.

    Wagle AM, Yeo TK, Au Eong KG.

    Lancet. 2007 Oct 27;370(9597):1481. No abstract available. PMID: 17964347 [PubMed - indexed for MEDLINE]Related articles

    4.

    56,000 Ways? No way!

    Brown GC.

    Curr Opin Ophthalmol. 2006 Jun;17(3):219-22. No abstract available. PMID: 16794432 [PubMed - indexed for MEDLINE]Related articles

    5.

    Measurement of the economic impact of visual impairment from age-related macular degeneration in Australia.

    Hopley C, Carter R, Mitchell P.

    Clin Experiment Ophthalmol. 2003 Dec;31(6):522-9.PMID: 14641161 [PubMed - indexed for MEDLINE]Related articles

    6.

    Economic evaluation of blind rehabilitation for veterans with macular diseases in the Department of Veterans Affairs.

    Stroupe KT, Stelmack JA, Tang XC, Reda DJ, Moran D, Rinne S, Mancil R, Wei Y, Cummings R, Mancil G, Ellis N, Massof RW.

    Ophthalmic Epidemiol. 2008 Mar-Apr;15(2):84-91.PMID: 18432491 [PubMed - indexed for MEDLINE]Related articles

    7.

    Economic cost of age-related macular degeneration: a review of recent research.

    Ke KM, Chakravarthy U, O'Neill C.

    Drugs Aging. 2006;23(3):217-25. Review.PMID: 16608377 [PubMed - indexed for MEDLINE]Related articles

    8.

    Cost utility of photodynamic therapy for predominantly classic neovascular age related macular degeneration.

    Hopley C, Salkeld G, Mitchell P.

    Br J Ophthalmol. 2004 Aug;88(8):982-7.PMID: 15258009 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The cost of vision for vitreoretinal interventions.

    Smiddy WE.

    Curr Opin Ophthalmol. 2008 May;19(3):195-201. Review.PMID: 18408493 [PubMed - indexed for MEDLINE]Related articles

    10.

    Age-related macular degeneration: the costs to society and the patient.

    Gupta OP, Brown GC, Brown MM.

    Curr Opin Ophthalmol. 2007 May;18(3):201-5. Review.PMID: 17435426 [PubMed - indexed for MEDLINE]Related articles

    11.

    Pharmacoeconomics and macular degeneration.

    Brown GC, Brown MM, Brown H, Godshalk AN.

    Curr Opin Ophthalmol. 2007 May;18(3):206-11. Review.PMID: 17435427 [PubMed - indexed for MEDLINE]Related articles

    12.

    Relative cost of a line of vision in age-related macular degeneration.

    Smiddy WE.

    Ophthalmology. 2007 May;114(5):847-54. Epub 2007 Feb 16. Review.PMID: 17306878 [PubMed - indexed for MEDLINE]Related articles

    13.

    Prevalence of blindness caused by senile macular degeneration in Greenland.

    Rosenberg T.

    Arctic Med Res. 1987 Oct;46(2):64-70. No abstract available. PMID: 3426774 [PubMed - indexed for MEDLINE]Related articles

    14.

    The burden of age-related macular degeneration: a value-based analysis.

    Brown MM, Brown GC, Sharma S, Stein JD, Roth Z, Campanella J, Beauchamp GR.

    Curr Opin Ophthalmol. 2006 Jun;17(3):257-66. Review. Erratum in: Curr Opin Ophthalmol. 2006 Jun;17(3):265. PMID: 16794438 [PubMed - indexed for MEDLINE]Related articles

    15.

    Does age-related macular degeneration (AMD) cause blindness?

    [No authors listed]

    Johns Hopkins Med Lett Health After 50. 2000 Jul;12(5):8. No abstract available. PMID: 10879155 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Cost-effectiveness of photodynamic therapy in age-related macular degeneration]

    Muslera E, Natal C.

    Arch Soc Esp Oftalmol. 2006 Apr;81(4):199-204. Spanish. PMID: 16688643 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation.

    Colquitt JL, Jones J, Tan SC, Takeda A, Clegg AJ, Price A.

    Health Technol Assess. 2008 May;12(16):iii-iv, ix-201. Review.PMID: 18462575 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    A value-based medicine comparison of interventions for subfoveal neovascular macular degeneration.

    Brown GC, Brown MM, Brown HC, Kindermann S, Sharma S.

    Ophthalmology. 2007 Jun;114(6):1170-8. Epub 2007 Feb 23.PMID: 17320964 [PubMed - indexed for MEDLINE]Related articles

    19.

    Update on utilities and cost-utility analyses.

    Hollands H, Sharma S.

    Curr Opin Ophthalmol. 2006 Jun;17(3):223-7. Review.PMID: 16794433 [PubMed - indexed for MEDLINE]Related articles

    20.

    Burden of illness of neovascular age-related macular degeneration in Canada.

    Cruess A, Zlateva G, Xu X, Rochon S.

    Can J Ophthalmol. 2007 Dec;42(6):836-43.PMID: 18026200 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity